Latest California Healthline Stories
Vapers Seek Relief From Nicotine Addiction In — Wait For It — Cigarettes
Even though e-cigarette makers market their products as a safer alternative to cigarettes, a growing number of vapers are trying to quit— and they’re turning to cigarettes to help them.
Mysterious Vaping Lung Injuries May Have Flown Under Regulatory Radar
Doctors who saw patients with a mysterious lung illness in the past suspected vaping as the cause but didn’t know where to report such cases. “It wasn’t that I didn’t want to report it, it’s that there’s no pathway,” said one California pulmonologist.
Shopping Abroad For Cheaper Medication? Here’s What You Need To Know
Americans routinely skirt federal law by crossing into Canada and Mexico or tapping online pharmacies abroad to purchase prescription medications at a fraction of the price they would pay at home. Is it safe? Not necessarily. Here’s some advice.
¿Buscas medicamentos más baratos en el exterior? Esto es lo que debes saber
Los estadounidenses eluden la ley federal cruzando a Canadá y México, o recurriendo a farmacias en línea en el extranjero para comprar medicamentos recetados a una fracción del precio que pagarían en casa.
Tecnología casera ofrece más libertad a los pacientes para controlar su diabetes
La diabetes tipo 1 es una condición crónica que requiere un estricto control de la glucosa y la administración de la cantidad de insulina precisa. Pacientes crearon un sistema para mantener ese equilibrio vital.
DIY Tech Gives People More Freedom In Managing Diabetes
People with diabetes say they’ve been waiting for years for better technology to manage their chronic condition. Tired of waiting, some tech-savvy, do-it-yourselfers are constructing their own devices using open-source programming instructions.
Five Things We Found In The FDA’s Hidden Device Database
The Food and Drug Administration released two decades of previously hidden data containing millions of injuries or malfunctions by medical devices. Here’s what we’ve learned so far.
FDA Overlooked Red Flags In Drugmaker’s Testing of New Depression Medicine
In March, a chemical cousin of the anesthetic and club drug ketamine was approved for the treatment of patients with intractable depression. But critics say studies presented to the FDA provided at best modest evidence it worked and did not include information about the safety of the drug, Spravato, for long-term use.
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don’t have to.
More Than Half Of Surgical Stapler Malfunctions Went To Hidden FDA Database
The FDA reveals that 56,000 malfunctions associated with surgical staplers weren’t reported through its traditional public reporting system.